Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector.

@article{Hahn2000EvaluationOT,
  title={Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector.},
  author={Stephen M. Hahn and Murali Cherukuri Krishna and A M Deluca and Deborah Coffin and James B. Mitchell},
  journal={Free radical biology & medicine},
  year={2000},
  volume={28 6},
  pages={953-8}
}
Nitroxides are stable free radical compounds that protect against the toxicity of reactive oxygen species in vitro and in vivo. Tempol (Aldrich, Milwaukee, WI, USA) is a cell-permeable hydrophilic nitroxide and has been shown to be an in vitro and in vivo radioprotector. The limitations of Tempol as a systemic radioprotector are that it causes substantial reductions in arterial blood pressure when administered intravenously and is associated with seizure activity. Furthermore, Tempol is rapidly… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…